Baker Bros. Advisors (GP) LLC's Net Worth

$1.77 Billion

Estimate Recalculated Feb 21, 2024 07:10PM EST

Who is Baker Bros. Advisors (GP) LLC?

Baker Bros. Advisors (GP) LLC has an estimated net worth of $1.77 Billion. This is based on reported shares across multiple companies, which include Seagen Inc., RHYTHM PHARMACEUTICALS, INC., BeiGene, Ltd., INCYTE CORP, Invitae Corp, Prelude Therapeutics Inc, XOMA Corp, Kiniksa Pharmaceuticals, Ltd., Mirati Therapeutics, Inc., Zymeworks Inc., Intellia Therapeutics, Inc., Entrada Therapeutics, Inc., IGM Biosciences, Inc., Kodiak Sciences Inc., ACADIA PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., TScan Therapeutics, Inc., Neoleukin Therapeutics, Inc., Atreca, Inc., Aeglea BioTherapeutics, Inc., BELLICUM PHARMACEUTICALS, INC, HOOKIPA Pharma Inc., Talis Biomedical Corp, ALEXION PHARMACEUTICALS, INC., MADRIGAL PHARMACEUTICALS, INC., SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, and Principia Biopharma Inc..

SEC CIK

Baker Bros. Advisors (GP) LLC's CIK is 0001580575

Past Insider Trading and Trends

2016 was Baker Bros. Advisors (GP) LLC's most active year for acquiring shares with 455 total transactions. Baker Bros. Advisors (GP) LLC's most active month to acquire stocks was the month of April. 2019 was Baker Bros. Advisors (GP) LLC's most active year for disposing of shares, totalling 379 transactions. Baker Bros. Advisors (GP) LLC's most active month to dispose stocks was the month of October. 2013 saw Baker Bros. Advisors (GP) LLC paying a total of $53,602,564,871.66 for 542,479,071 shares, this is the most they've acquired in one year. In 2013 Baker Bros. Advisors (GP) LLC cashed out on 117,319,500 shares for a total of $49,999,437,165.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.875

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+176.03%
2.05M
$17.00
$15,045,000.00
3.21M
Oct 5
Form 3
0
0
No matching records found

BeiGene, Ltd. (BGNE) Snapshot price: $148.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.43%
-1.10M
$180.50
-$198,550,000.00
10.57M
Nov 14
Form 4
+38.25%
51.69K
186.83K
Jun 15
Form 4
+97.65%
66.77K
135.14K
Jun 22
Form 4
+83.93%
31.2K
68.37K
Jun 16
Form 4
-1.03%
-121.15K
$220.50
-$26,714,457.00
11.67M
Jan 4
Form 4
-11.53%
-1.54M
$220.50
-$333,295,893.00
11.81M
Oct 13 - Dec 4
Form 4
+276.32%
14.58M
$14.23
$207,544,548.74
19.86M
Jul 15
Form 4
0
0
Jun 17
Form 4
-35.69%
-651.49K
1.17M
Jun 5 - Jun 6
Form 4
+15,636.87%
5.81M
$108.00
$627,922,800.00
5.85M
Aug 2
Form 4
+0.05%
37.16K
79.73M
Jun 6
Form 4
+51.44%
1.98M
$101.00
$199,999,998.00
5.83M
Jan 18
Form 4
-71.13%
-35.00K
14.2K
Oct 13
Form 4
+4.79%
176.06K
$71.00
$12,499,976.00
3.85M
Aug 11
Form 4
0
0
Apr 19
Form 4
+92.04%
1.76M
$32.00
$56,335,840.00
3.67M
Nov 18
Form 4
+64.92%
82.25M
$10.01
$47,654,320.28
208.94M
Feb 8
Form 3
0
0
No matching records found

Invitae Corp (NVTA) Snapshot price: $0.032

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.40%
1.11M
$4.50
$4,999,999.50
8.33M
Mar 28
Form 4
0
0
Jul 31
Form 4
+11.31%
733.33K
$6.00
$4,399,998.00
7.21M
Nov 17
Form 3
0
0
No matching records found

Prelude Therapeutics Inc (PRLD) Snapshot price: $2.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Dec 13
Form 4
0
0
Jun 16
Form 4
0
0
May 22
Form 4
0
0
Jun 17
Form 4
0
0
Jun 18
Form 4
+0.10%
10.38K
$12.85
$133,331.60
10.13M
Jan 27
Form 4
0
0
Jan 11
Form 4
+49.15%
9.91M
$19.00
$29,999,993.00
30.08M
Mar 27 - Sep 29
Form 3
0
0
No matching records found

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.62%
17.49K
2.84M
Jun 6
Form 4
+0.71%
20K
2.82M
Jun 29
Form 4
0
0
Jun 29
Form 4
0
0
Jul 24
Form 4
0
0
Jun 30
Form 4
0
0
May 18
Form 4
-57.03%
-170.74K
128.66K
Jun 6
Form 4
0
0
May 29
Form 4
0
0
Feb 4
Form 4
3M
$18.00
$54,000,000.00
3M
Feb 9 - May 29
Form 3
0
0
No matching records found